Good afternoon, ladies and gentlemen, and welcome to Cathay General Bancorp's Fourth Quarter and Full Year 2025 Earnings ...

Vornado Realty Trust (NYSE:VNO) announced today that it will file its annual report on Form 10-K for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission and issue its ...

(NYSE: ALX) today announced that it will file its annual report on Form 10-K for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission and issue its fourth quarter and full ...

VANCOUVER, British Columbia, January 12, 2026--lululemon athletica inc. (NASDAQ:LULU) today announced that the Company now ...

LightPath Technologies, Inc. (NASDAQ: LPTH) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today ...

Increased CARVYKTI® manufacturing capacity with the physical expansion of the Raritan facility, now the largest cell therapy ...

Vera Therapeutics, Inc. ('Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic ...

Krish S. Krishnan, Chairman and Chief Executive Officer, and Suma M. Krishnan, President of Research and Development, will highlight these updates and Krystal’s strategic vision in a presentation at ...

Management to highlight company strategy, successful acquisition track record, Seemann/MSC capabilities and financial ...

The presentation will begin at 3:00 p.m. ET and will be webcast live within the Investors section of the Company's website. Interested parties may also register for the webcast in advance ...

Phase 2 trial of GX-03 for moderate-severe atopic dermatitis on track to complete both interim analysis and topline data in ...

Mr. Adi Sfadia, Chief Executive Officer, and Mr. Gil Benyamini, Chief Financial Officer, will be available for one-on-one meetings with investors at the conference. Management will also host a ...